Dr. Howard I. Scher, PCCTC Scientific Oversight Committee Chair, speaks on predicting sensitivity to prostate cancer treatments.
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.